logo
The House Next Door Has Black Mold. Do I Tell Potential Tenants?

The House Next Door Has Black Mold. Do I Tell Potential Tenants?

New York Times18-06-2025
My wife and I live in a neighborhood of single-family homes, most of which are owner-occupied. The home next door, however, is rented out by an absentee landlord. We became friendly with the previous tenants, who moved out very abruptly a couple of weeks ago. We learned from them that the house is infested with black mold, as identified by a professional testing company, and they shared the results with us. The mold issue was serious enough to cause health issues for the previous tenants. To our knowledge, the landlord has done nothing to mitigate this issue, and now he has listed the house for rent again. Our concern is that we've seen families with small children looking at the house. We believe that we might be in legal jeopardy if we were to inform prospective tenants about the mold issue, but what is our moral obligation? — Name Withheld
From the Ethicist:
In the late 1990s, Stachybotrys chartarum — sometimes dubbed 'toxic black mold' — became the subject of national alarm, with news stories linking it to devastating health effects. Much of that panic was later walked back after scientific review. Still, people with allergies can experience a stuffy or runny nose and the like from mold exposure, while for people with asthma, compromised immune systems or simply bad luck, mold exposure can be genuinely harmful. In children, mold exposure has been associated with an increased risk of developing asthma. In every state, a landlord implicitly promises that a rental property is habitable. What counts as 'habitable' varies by jurisdiction, but a serious mold problem most likely violates that standard.
If the previous tenants shared their testing results with you, try to get a copy, if you haven't already. You'll want to satisfy to yourself, too, that the company doing the mold inspection is on the up-and-up; notoriously, there can be a conflict of interest when the people doing the inspections are also in the remediation business. ('In most cases, if visible mold growth is present, sampling is unnecessary,' the E.P.A. advises, while the C.D.C. flatly says that it 'does not recommend mold testing,' noting that 'there are no set standards for what is and what is not an acceptable quantity of different kinds of mold in a home.') Assuming the problem has been correctly identified, you might write the landlord, asking whether the issue has been addressed, and sharing your health concerns.
If you're convinced that the danger remains, you could share the documentation with the agent listing this rental property. Realtors have their own ethical and legal obligations: If they believe the home is uninhabitable, they can't simply let tenants assume the risk. And they're unlikely to want to expose themselves to legal jeopardy for concealing a defect. (Disclosing facts shouldn't expose you to legal jeopardy, but that's a question for a lawyer.)
You're not under a moral obligation to act, and you wouldn't be wrong to stay out of it. But this is the kind of gesture that, when well-informed, can make the world a little better. If a child were to suffer because no one spoke up, you might wish you had said something. If you were the one about to move in, you would want to know. A decent society depends, in part, on people who choose to help when they don't strictly have to.
Want all of The Times? Subscribe.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

The Wistar Institute Receives $17 Million NIH Grant for Personalized HIV Cure Research
The Wistar Institute Receives $17 Million NIH Grant for Personalized HIV Cure Research

Yahoo

time19 minutes ago

  • Yahoo

The Wistar Institute Receives $17 Million NIH Grant for Personalized HIV Cure Research

Philadelphia-led consortium is selected to tailor HIV curative strategies to participant Philadelphia, PA, Aug. 19, 2025 (GLOBE NEWSWIRE) -- The Wistar Institute announces the National Institutes of Health (NIH) granted a five-year, $17 million research award to launch iCure Consortium to develop individualized 'cure regimens' for HIV. The Wistar-led, iCure Consortium's objective is to advance strategies to cure HIV through tailored personalized medicine. 'Today 38 million people still live with HIV worldwide, and 1.3 million contract the virus each year,' said Luis J. Montaner, D.V.M., iCure principal investigator, executive vice president of The Wistar Institute and director of Wistar's HIV Cure and Viral Diseases Center. 'For the first time, this grant brings our best team together working towards a cure tailored to each participant by pairing the latest in neutralizing antibody and cell-therapy breakthroughs against the unique, person-specific features of HIV.' iCure Consortium will test a six-part, individually-tailored therapy designed to wipe out the persistent viral reservoir that remains after antiretroviral therapy in an effort to deliver durable, drug-free remission. The project combines six advanced tactics—neutralizing antibodies, mRNA therapy, viral binders, engineered CAR-T and 'Natural Killer' (NK) cells, and precision latency 'wake-up' drugs—all designed against each patient's unique virus. 'Ending HIV demands more than management—it demands eradication,' said Drew Weissman, M.D., Ph.D., iCure co‑principal investigator, 2023 Nobel Laureate and Roberts Family Professor in Vaccine Research at the Perelman School of Medicine at the University of Pennsylvania. 'This project now allows us to apply our breakthroughs in RNA therapy as part of a cure-directed strategy.' How iCure Works• Wake the latent virus• Map and target unique weak spots with tailored antibodies• Destroy infected cells using 'super‑charged' CAR‑T and NK cells• Enhance clearance and block relapse with bispecific binders In the first step, researchers reactivate the virus in a sample of the participant's blood and identify mutations that the participant has not yet developed antibodies against. They then develop a tailored antibody therapy cocktail specifically designed against these specific mutations. In the next stage, researchers focus on preventing HIV from returning. To do this, they develop person-specific antibodies or small molecule binders that can act as 'homing devices' — beacons that can lead immune cells to the latent virus. Then they genetically modify CAR-T cells and NK cells (immune cells that destroy viruses) to express or use these homing devices to better clear infected cells. Finally, researchers further enhance NK cells. First, they develop stronger and more durable cells, called adaptive NK cells, by supercharging their virus-killing ability. Then, they deploy small-molecule drugs called bispecifics, which bind NK cells to the infected cells they are targeting. "iCure takes full advantage of the advances made in understanding how and where HIV hides from the immune system," said Montaner. "We've built on our knowledge and can use that information to identify a first of its kind targeting to a person's unique HIV features." iCure furthers the research groundwork laid by the BEAT-HIV Martin Delaney Collaboratory ( a Philadelphia-based consortium of more than 95 leading HIV researchers co-led by Dr. Montaner. Montaner called the NIH grant a 'once in a lifetime opportunity' that reflects Wistar's track record as a scientific leader in the effort to develop an HIV cure, as well as its grassroots support and collaboration with the HIV community. 'By the end of this study we hope to have a process by which to identify the virus that we need to go after in each person and have a basis to design clinical trials choosing the best of these strategies to move forward,' said Montaner. Other institutions participating in this study include Johns Hopkins Medicine and iCure co-principal investigator Robert Siliciano, M.D., Ph.D., the University of Pennsylvania, Philadelphia FIGHT, the Ragon Institute at Harvard University, George Washington University, Duke University, and Massachusetts Institute of Technology. The iCure program is funded by the National Institute of Allergy and Infectious Diseases, part of NIH, under award number UM1AI191272. ### The Wistar Institute is an international leader in biomedical research with special expertise in cancer research and vaccine development. Founded in 1892 as the first independent nonprofit biomedical research institute in the United States, Wistar has held the prestigious Cancer Center designation from the National Cancer Institute since 1972. The Institute works actively to ensure that research advances move from the laboratory to the clinic as quickly as possible. CONTACT: Darien Sutton The Wistar Institute 215-870-2048 dsutton@ in to access your portfolio

Researchers Find Strange Link Between Marathon Running and Cancer
Researchers Find Strange Link Between Marathon Running and Cancer

Gizmodo

time20 minutes ago

  • Gizmodo

Researchers Find Strange Link Between Marathon Running and Cancer

Some of the most physically fit people in the world may have a unique health risk. New research uncovers a possible link between marathon running and colorectal cancer. Oncologists at the Inova Schar Cancer Institute in Virginia conducted the study, which examined the colons of relatively young people who had run several long-distance races. They found these runners had a much higher rate of having potentially dangerous adenomas (a type of polyp) than would be expected for their age. Though the findings are preliminary and require more confirmation, they may point to a real connection between colorectal cancer and extreme physical activity. 'It tells us there's a signal here,' David Lieberman, a gastroenterologist and professor emeritus at Oregon Health and Science University not affiliated with the study, told the New York Times Tuesday. 'We wouldn't have expected these rates of high-risk adenomas, which are cancer precursor lesions, in an age group like this.' Lead researcher Timothy Cannon was inspired to perform the study after he treated three young patients with colorectal cancer, all of whom had run ultramarathons (defined as any race longer than 26.2 miles). Not only were his patients fit, but they were also much younger than the typical case, the oldest being 40. In 2022, Cannon and his colleagues began recruiting endurance athletes for their prospective study. The volunteers had all run at least two ultramarathons or five regular marathons; they also had no family history of colorectal cancer or other apparent risk factors. All told, 100 athletes between the ages of 35 and 50 took part and were given colonoscopies. People Who Are More Flexible Tend to Live Longer, Study Finds The researchers went looking for advanced adenomas in the colons of their volunteers, relatively large or otherwise unusual polyps. Though these growths are themselves benign, they have a higher risk of turning cancerous than other polyps. Then they compared the rate of finding these polyps in their athletes to historical trends. About 1.2% of people in their 40s at average risk for colorectal cancer would be expected to have advanced adenomas, according to the researchers. By sharp contrast, 15% of the runners they studied had them, while nearly half had polyps in general. 'Consideration of refined screening strategies for this population is warranted,' the researchers wrote in their study. The team presented its results earlier this year at the annual conference of the American Society of Clinical Oncology. That means this study hasn't yet undergone the formal peer-review process. The authors are also quick to note their work isn't definitive proof that endurance running can cause colorectal cancer. Assuming this link is causative, there remains the burning question of why. As even weekend 5k joggers will know, running can occasionally trigger bouts of gastrointestinal distress (the namesake runner's diarrhea). These injuries are sometimes caused by temporarily restricted blood flow to the intestines that damages nearby cells. It's possible, the researchers speculate, that extreme runners who regularly experience this blood flow loss can develop the sort of chronic inflammation that makes cancer more likely to emerge. Being a Couch Potato Is Bad for Your Memory, Study Warns At this point, though, that's only one hypothesis for what may be happening here. The researchers say future studies should try to confirm their findings as well as untangle the causes and risk factors that could explain this potential higher risk. All that said, this research shouldn't scare anyone away from running or any other form of cardio. The many health benefits of regular physical activity—which importantly include a lower risk of at least eight different types of cancer—still far outweigh the risks for the average person.

The Necessity of ObamaCare
The Necessity of ObamaCare

Wall Street Journal

time22 minutes ago

  • Wall Street Journal

The Necessity of ObamaCare

In 'The Phantom Patients of ObamaCare' (Aug. 18), you write that because millions of Americans 'don't use' their subsidized insurance, they therefore 'don't need' it. Yet as we teach our students every year, this misunderstands the purpose of insurance. Not filing a claim doesn't mean you didn't need insurance. We've never had to use our oxygen masks during decades of flying, but that hardly means they're not essential. Prof. Amy Finkelstein

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store